Does Dr. VICKY SAVAS have financial conflicts of interest?

Dr. VICKY SAVAS (MD) has received a total of $8,523 in pharmaceutical and medical device industry funding between 2021 and 2024. This includes $8,523 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. VICKY SAVAS?

According to CMS Open Payments data, Dr. VICKY SAVAS received funding from E.R. SQUIBB & SONS, L.L.C ($1,061), BOEHRINGER INGELHEIM PHARMACEUTICALS ($1,060), and PFIZER ($921).

Does Dr. VICKY SAVAS receive research grants or speaking fees?

Dr. VICKY SAVAS has received $8,523 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. VICKY SAVAS

MDReal-Time Hydrated

Specialty: Internal Medicine, Cardiovascular Disease

Practice Location: SOUTHFIELD, MI 48034

NPI Number: 1851348494

LIFETIME INDUSTRY VALUE

$8,523

2021 – 2024 Cumulative

Conflict of Interest Analysis

Dr. SAVAS is a verified Internal Medicine, Cardiovascular Disease practitioner based in SOUTHFIELD, MI.

Between 2021 and 2024, Dr. SAVAS had an overall industry promotional and research financial footprint of $8,523 as recorded in the federal CMS Open Payments database.

$8,523 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. SAVAS's primary funding source is E.R. SQUIBB & SONS, L.L.C, which accounts for $1,061 (representing 12.4% of overall industry footprint).

Data coverage: 2021 – 2024 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

E.R. SQUIBB & SONS, L.L.C

Rank 1

$1,061

12.4%

BOEHRINGER INGELHEIM PHARMACEUTICALS

Rank 2

$1,060

12.4%

PFIZER

Rank 3

$921

10.8%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2024

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.